Announcements
1 April 2022
Prof. Dr. Markus R. Meyer Appointed Editor-in-Chief of Metabolites
We are pleased to announce that Prof. Dr. Markus R. Meyer has been appointed as the Editor-in-Chief of Metabolites (ISSN: 2218-1989).
|
|
Name: Prof. Dr. Markus R. Meyer |
The following is a short Q&A with Prof. Dr. Markus R. Meyer, who shared his vision for the Section with us as well as his views on the research area.
- What appealed to you about the journal that made you want to take on the role as its Editor-in-Chief?
The knowledge of the fate, modulation, and change of endogenous and exogenous compounds is fundamental in various disciplines. This includes research ranging from studying new biomarkers for diseases to the quality control of food. Papers published in Metabolites provide such crucial knowledge.
- What is your vision for the journal?
The journal Metabolites needs to develop further towards being one of the benchmark journals in key areas, such as metabolomics. This means that the journal has to stay and become more attractive to scientists, which is reflected by, e.g., a high impact factor in addition to a rigorous and straightforward reviewing and publishing procedure.
- What does the future of this field of research look like?
To analyze the fate of endogenous and exogenous compounds is fundamental in biosciences, and with the expected advances in analytical techniques and data science, this role will grow in the future.
- What do you think of the development of Open Access in the publishing field?
Open access agreements, such as the 2020 “DEAL” agreement, are important to increase the acceptance and use of open access publishing, particularly for academic and research institutions.
We warmly welcome Prof. Dr. Markus R. Meyer to his new role as Editor-in-Chief, and we look forward to his leading Metabolites to many more milestones.
Metabolites Editorial Office
